Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. CL
3. SNDK
4. TAP
5. DELL
6. ROIV
7. ANET
8. NKE
9. PANW
10. SPG

Go back to Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
(NASDAQ: BBIO) Delayed: 74.84 -0.57 (0.76%)
Previous Close $75.41    52 Week High $ 
Open $74.98    52 Week Low $ 
Day High $75.37    P/E N/A 
Day Low $74.11    EPS $ 
Volume 1,540,365